IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

The role of type-2 interferon (IFNγ) in antiviral immunity.

Myrobalan secures funding for CNS drug development

Share this article Myrobalan will use the funds to develop drugs for treating ailments of the central nervous system (CNS). Credit: Billion Photos/Shutterstock.com. Myrobalan Therapeutics

January 11, 2024

NCCN publishes first-ever treatment recommendations pertaining to neuroblastoma

The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers-;today published its first ever set of treatment recommendations pertaining to neuroblastoma.

February 8, 2024

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer to include patients with mismatch repair proficient/microsatellite stable

August 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.